| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Gross Sales | 4,77,521.05 | 4,76,632.79 | 4,29,500.77 | 4,05,398.5 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 4,77,521.05 | 4,76,632.79 | 4,29,500.77 | 4,05,398.5 |
Other Operating Income | 3,69,135.14 | 3,08,670.77 | 2,94,105.52 | 2,85,515.33 |
Other Income | 14,860.59 | 7,920.25 | 929.72 | 12,790.53 |
Total Income | 8,61,516.78 | 7,93,223.81 | 7,24,536 | 7,03,704.36 |
Total Expenditure | 8,18,636.88 | 7,55,940.54 | 7,16,594.51 | 6,92,270.32 |
PBIDT | 42,879.9 | 37,283.27 | 7,941.49 | 11,434.04 |
Interest | 0 | 0 | 0 | 0 |
PBDT | 42,879.9 | 37,283.27 | 7,941.49 | 11,434.04 |
Depreciation | 0 | 0 | 0 | 0 |
Minority Interest Before NP | 0 | 0 | 0 | 0 |
Tax | 6,097.69 | 5,466.25 | 8,013.17 | 9,176.73 |
Deferred Tax | 0 | 0 | 0 | 0 |
Reported Profit After Tax | 36,782.21 | 31,817.02 | -71.68 | 2,257.31 |
Minority Interest After NP | -31.08 | 2.03 | 6.19 | 446.53 |
Net Profit after Minority Interest | 40,915.85 | 35,996.64 | 4,124.71 | 2,974.14 |
Extra-ordinary Items | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 40,915.85 | 35,996.64 | 4,124.71 | 2,974.14 |
EPS (Unit Curr.) | 64.69 | 56.91 | 0 | 0 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 |
Dividend (%) | 100 | 30 | 0 | 0 |
Equity | 6,325 | 6,325 | 6,325 | 100 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 |
PBIDTM(%) | 8.97 | 7.82 | 1.84 | 2.82 |
PBDTM(%) | 8.97 | 7.82 | 1.84 | 2.82 |
PATM(%) | 7.7 | 6.67 | -0.01 | 0.55 |
The company expects to close and announce the acquisition no later than March 31. LIC's stake in the acquired health insurance company will not be majority.
The pharma company caters to various international markets, reinforcing its position as a key player in the pharmaceutical industry.
Additionally, financial impact is limited to the demand amount and shall have no material impact on its overall operations.
Here are some of the stocks that may see significant price movement today: Biocon, NTPC Green Energy, LIC, etc.
Patanjali Foods reported a net profit of ₹309 crore for Q2 FY25, showing a 21.4% year-on-year growth compared to ₹254.5 crore in Q2 FY24.
In Q2 FY25, LTIMindtree recorded a consolidated net profit of ₹1,251 Crore, up 7.7% from ₹1,161.8 Crore last year.
It was followed by Adani Ports, where the LIC's investment value fell by ₹2,959 Crore. The stock fell by ₹174.35 per share, or 13.53%
Here are some of the stocks that may see significant price movement today: Adani Group, Nippon Life India AMC, Tata Power, etc.
LIC's ownership of NSE-listed companies dropped from 3.64% in the previous quarter to an all-time low of 3.59%.
Additionally, it reduced its stake in Aurobindo Pharma from 5.01% to 2.265% between November 2021 and September 2024.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
